FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Debate Over Vaccine EUA Described

[ Price : $8.95]

A detailed Washington Post story explores the pressures on FDA to authorize or approve a Covid-19 vaccine within the next few week...

CDER Touts Role in Metformin NDMA Studies

[ Price : $8.95]

CDER says its more extensive testing found NDMA in only eight of 16 metformin samples in which it was found by a private laborator...

FDA Clears SoftWave Technology for Burn Healing

[ Price : $8.95]

FDA clears a SoftWave Tissue Regeneration Technologies 510(k) for using its SoftWave technology for treating superficial, partial-...

Pharmacokinetics for Impaired Renal Function Guidance

[ Price : $8.95]

FDA issues a revised and updated draft guidance on pharmacokinetic study design and analysis for patients with impaired renal func...

Pull Mifeprex from Market: Senators

[ Price : $8.95]

Sen. Ted Cruz and 19 other senators call on FDA to order the abortion drug Mifeprex off the U.S. market.

Athenex NDA for Breast Cancer Drug

[ Price : $8.95]

FDA accepts for priority review an Athenex NDA for oral paclitaxel and encequidar for treating metastatic breast cancer.

Alphamab Orphan Status for KN046 in Thoracic Tumors

[ Price : $8.95]

FDA grants Alphamab Oncology an orphan drug designation for KN046, a recombinant humanized antibody for treating thymic epithelial...

Orange Book Listings Need Clarification: Comments

[ Price : $8.95]

Three stakeholders say FDA should provide additional clarification on the rules for listing patents in the Orange Book.

KV Pharmas Micro-K LS Not Withdrawn Over Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that KV Pharmaceuticalֺs Micro-K LS (potassium chloride) extended-release liquid sus...

Federal Register Corrected in NDA Withdrawals

[ Price : $8.95]

Federal Register notice: FDA corrects a 5/14 Federal Register notice on 16 NDA withdrawals from multiple applicants.